Profile

Cover photo
113 followers|7,071 views
AboutPostsPhotosVideos

Stream

BioTime

Shared publicly  - 
 
BioTime to Present at the Jefferies 2015 Global Healthcare Conference http://bit.ly/1F26vnY
1
Add a comment...

BioTime

Shared publicly  - 
 
BioTime company OncoCyte completes equity financing round http://bit.ly/1K8ETUN $BTX
1
Add a comment...

BioTime

Shared publicly  - 
 
BioTime’s Subsidiary Cell Cure Neurosciences Ltd. Awarded $1.6 Million Grant From Israel’s Office of the Chief Scientist
1
Add a comment...

BioTime

Shared publicly  - 
 
BioTime, Inc. Reports First Quarter 2015 Results and Recent Corporate Accomplishments
1
Add a comment...

BioTime

Shared publicly  - 
 
BioTime company Asterias Biotherapeutics Reports First Quarter Results
1
Add a comment...

BioTime

Shared publicly  - 
 
BioTime company Asterias Biotherapeutics to Host Investor Meeting to Review Clinical Development Strategy for AST-OPC1 in Spinal Cord Injury

>Dr. John Steeves, Co-Chair of Spinal Cord Outcomes Partnership Endeavor, to Discuss Clinical Foundations for Endpoints and Outcome Measures in Spinal Cord Injury Trials

>Webcast Scheduled at 9:30 a.m. ET on May 8, 2015
1
Add a comment...
Have them in circles
113 people
downie Tracy's profile photo
balluch Sharon's profile photo
Fgj Rodriguez's profile photo
Jasmine Hauser's profile photo
Jerri Moses's profile photo
Bobbie Gerhardt's profile photo
Jimmy Scott's profile photo
CorCell's profile photo
Nelson Maryann's profile photo

BioTime

Shared publicly  - 
 
BioTime company OncoCyte reports that its Collaborators at The Wistar Institute Present Positive Clinical Interim Results of Blood-Based Diagnostic Test for Non-Invasive Detection of Lung Cancer

> Data Presented at 2015 American Thoracic Society International Conference
1
Add a comment...

BioTime

Shared publicly  - 
 
BioTime company Asterias Biotherapeutics Announces Availability of Abstract with Phase 2 Clinical Data on Cancer Vaccine AST-VAC1 in Acute Myelogenous Leukemia (AML)

>Data to be Featured in Oral Presentation at the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting  http://bit.ly/1E7KKBl
1
Add a comment...

BioTime

Shared publicly  - 
 
BioTime company LifeMap Solutions pens inaugural post on official Apple ResearchKit blog https://lnkd.in/eFKFaEu
May 7, 2015. Preliminary User-Engagement Learning from our ResearchKit-Enabled Asthma Health App. With our partner Mount Sinai, we launched Asthma Health, one of the inaugural apps built on ResearchKit. The objective of the study is to gain greater insight into triggers of the disease and, ...
1
Add a comment...

BioTime

Shared publicly  - 
 
Asterias Biotherapeutics Promotes Edward Wirth, M.D., Ph.D. to Chief Medical Officer http://bit.ly/1F1R5U2 $AST #regmed
1
Add a comment...

BioTime

Shared publicly  - 
 
Cell Cure Neurosciences Announces Preclinical Efficacy Data Demonstrating OpRegen® Preserves Vision
> Data to be Presented at Association for Research in Vision and Ophthalmology (ARVO) 2015 Annual Meeting
1
Add a comment...

BioTime

Shared publicly  - 
 
BioTime’s Clinical Grade Stem Cells From Subsidiary ES Cell International to Be Used in Planned CIRM-Funded Preclinical Studies of Huntington’s Disease
1
Add a comment...
People
Have them in circles
113 people
downie Tracy's profile photo
balluch Sharon's profile photo
Fgj Rodriguez's profile photo
Jasmine Hauser's profile photo
Jerri Moses's profile photo
Bobbie Gerhardt's profile photo
Jimmy Scott's profile photo
CorCell's profile photo
Nelson Maryann's profile photo
Contact Information
Contact info
Phone
(510) 521-3390
Story
Tagline
Developing stem cell-based therapies and products in the area of regenerative medicine
Introduction
BioTime, a biotechnology company headquartered in the San Francisco Bay Area, is focused on biomedical research and product development in regenerative medicine.